NCT00881075View on ClinicalTrials.gov

Safety and Efficacy of SeeMore (TM) in Heart Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Myocardial Infarction
Interventions
DRUG

SeeMore(TM)

single dose intravenous injectable

Sponsors
All Listed Sponsors
lead

Eagle Vision Pharmaceutical Corp.

INDUSTRY

NCT00881075 - Safety and Efficacy of SeeMore (TM) in Heart Patients | Biotech Hunter | Biotech Hunter